Jane Dickerson

Dr. Jane Dickerson

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in The Journal of Applied Laboratory Medicine
Verified
Journal Article
Closed access
PDF file
JDJane Dickerson
Jane Dickerson
AFAndrew H. Fletcher
Andrew H. Fletcher
GPGary Procop
Gary Procop
DKDavid F. Keren
David F. Keren
ISIla R. Singh
Ila R. Singh
MAMichael L. Astion
Michael L. Astion
Appropriate utilization of clinical laboratory services is important for patient care and requires institutional stewardship. Clinical laboratory stewardship programs are dedicated to improving the ordering, retrieval, and interpretation of appropriate laboratory tests. In addition, these programs focus on developing, maintaining, and improving systems to provide proper financial coverage for medically necessary testing. Overall, clinical laboratory stewardship programs help clinicians improve the quality of patient care while reducing costs to patients, hospitals, and health systems. This document, which was created by a new multiinstitutional committee interested in promoting and formalizing laboratory stewardship, summarizes core elements of successful hospital-based clinical laboratory stewardship programs. The core elements will also be helpful for independent commercial clinical laboratories.

21 November 2014 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
JDJane Dickerson
Jane Dickerson
MSMarian Sinkey
Marian Sinkey
KJKathleen Jacot
Kathleen Jacot
JSJennifer Stack
Jennifer Stack
KSKaterina Sadilkova
Katerina Sadilkova
RJRhona Jack
Rhona Jack

27 July 2016 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
PMPatrick C. Mathias
Patrick C. Mathias
JCJessie H. Conta
Jessie H. Conta
EKEric Q Konnick
Eric Q Konnick
DSDarci L. Sternen
Darci L. Sternen
SSShannon M. Stasi
Shannon M. Stasi
JDJane Dickerson
Jane Dickerson
Objectives: To characterize error rates for genetic test orders between medical specialties and in different settings by examining detailed order information. Methods: We performed a retrospective analysis of a detailed utilization management case database, comprising 2.5 years of data and almost 1,400 genetic test orders. After review by multiple reviewers, we categorized order modifications and cancellations, quantified rates of positive results and order errors, and compared genetics with nongenetics providers and inpatient with outpatient orders. Results: High cost or problems with preauthorization were the most common reasons for modification and cancellation, respectively. The cancellation rate for nongenetics providers was three times the rate for geneticists, but abnormal result rates were similar between the two groups. The approval rate for inpatient orders was not significantly lower than outpatient orders, and abnormal result rates were similar for these two groups as well. Order error rates were approximately 8% among tests recommended by genetics providers in the inpatient setting, and tests ordered or recommended by nongeneticists had error rates near 5% in both inpatient and outpatient settings. Conclusions: Clinicians without specialty training in genetics make genetic test order errors at a significantly higher rate than geneticists. A laboratory utilization management program prevents these order errors from becoming diagnostic errors and reaching the patient.

1 September 2016 in Clinical Biochemistry
Verified
Journal Article
Closed access
SLSheng-Ying Lo
Sheng-Ying Lo
CGCindy Gordon
Cindy Gordon
KSKaterina Sadilkova
Katerina Sadilkova
RJRhona M. Jack
Rhona M. Jack
JDJane Dickerson
Jane Dickerson

13 April 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
JDJane Dickerson
Jane Dickerson
JEJanet A. Englund
Janet A. Englund
XWXing Wang
Xing Wang
JBJulie C. Brown
Julie C. Brown
DZDanielle M. Zerr
Danielle M. Zerr
EKEileen J. Klein
Eileen J. Klein
Multiple factors may be associated with immune responses to SARS-CoV-2 vaccines. Factors potentially related to magnitude and durability of response include age, time, and vaccine reactogenicity. This study analyzed SARS-CoV-2 IgG spike antibody responses following the second dose of vaccine in healthcare workers (HCWs). Data were collected from participants enrolled in a longitudinal SARS-CoV-2 serology study over a 12-month period. Participants completed a survey documenting symptoms post-vaccination. Serum specimens were tested for SARS-CoV-2 IgG antibodies using the Abbott Architect AdvisdeDx SARS-CoV-2 IgGII assay. Antibody levels were compared against time from second vaccine dose, and symptoms following vaccination. Altogether, 335 women (86.6%) and 52 men (13.4%) participated. Median age was 37 years (IQR 30-43). Overall median antibody level was 2150.80 [1246.12, 3556.98] AU/mL (IQR). Age was not associated with antibody concentration (p-value = 0.10). Higher antibody responses (2253 AU/mL vs. 1506 AU/mL; p = 0.008) were found in HCWs with one or more symptoms after the second dose of the vaccine (n = 311). Antibody responses persisted throughout the study period post-vaccination; statistically significant decreases in antibody responses were observed over time (p < 0.001). Higher antibody response was associated with reactogenicity post-vaccine. Age and sex were not associated with higher antibody responses.

1 November 2016 in The Journal of Applied Laboratory Medicine
Verified
Journal Article
Open access
PDF file
SBSarah Brown
Sarah Brown
JDJane Dickerson
Jane Dickerson
Utilization management of laboratory testing is a trend increasing in relevance as the healthcare landscape continues to evolve toward value-based care, and many pediatric and adult laboratories are developing strategies for utilization management. The Pediatric Laboratory Guidance Service (PLUGS) started an annual conference dedicated to the important topics and challenges related to lab utilization. This year, the 2-day PLUGS Summit boasted over 10 hours of continuing medical education and several networking events to bring together leaders in the field of lab utilization. The theme of the 2016 meeting focused on bringing together clinical labs, reference labs, and insurance companies to increase the value of laboratory testing, in the context of the US health economy.